Core Insights - Cube Pharmaceuticals (003020.SZ) reported its Q3 2025 results on October 30, 2025, highlighting a total of 39.4014 million A-shares held by three institutional investors, representing 20.72% of the company's total share capital [1] Institutional Holdings - The institutional investors include Hefei Cube Investment Group Co., Ltd., China Merchants Fund Management Co., Ltd. - Social Security Fund 2108 Portfolio, and China Minsheng Bank Co., Ltd. - Invesco Great Wall Medical Health Mixed Securities Investment Fund [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.06 percentage points [1] Public Fund Activity - One new public fund disclosed its holdings in Cube Pharmaceuticals this quarter, specifically Invesco Great Wall Medical Health Mixed Class A [1] - A total of 60 public funds were not disclosed in this quarter compared to the previous one, including Hai Fu Tong Growth Value Mixed A, CITIC Construction Investment Rotation Mixed A, and others [1] Social Security Fund - One new social security fund disclosed its holdings in Cube Pharmaceuticals, which is the China Merchants Fund Management Co., Ltd. - Social Security Fund 2108 Portfolio [1]